Assessing Drug Epetraborole in Patients with Mycobacterium avium Complex Lung Disease (MACrO2)
Recruiting
18-99 years
All
5 participants needed
1 Location
Brief description of study
The purpose of this study is to learn about the effects of a study drug, Epetraborole, to assess the efficacy for treating refractory MAC. It will enroll patients over 18 years of age and will include the following: physical exams, CTs, medical history, ECGs, lung function tests, vital signs, safety labs, PK labs, and questionnaires.
Participants will be paid $50 for each study visit.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research, Mycobacterium avium Complex Lung Disease (MACrO2)
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 851421
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
